Invention Grant
- Patent Title: 5-HT3 receptor antagonists
-
Application No.: US16041875Application Date: 2018-07-23
-
Publication No.: US10407443B2Publication Date: 2019-09-10
- Inventor: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Todd Macklin , Maria Hopkins , Shota Kikuchi
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Barnes & Thornburg LLP
- Agent Scott Rothenberger
- Main IPC: A61K31/5386
- IPC: A61K31/5386 ; C07D498/08 ; C07D451/12 ; C07D471/04 ; C07D519/00 ; A61K31/19 ; C07D221/22 ; C07C53/40 ; C07D453/02 ; C07D471/08 ; C07C53/18
Abstract:
The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Public/Granted literature
- US20180327421A1 5-HT3 RECEPTOR ANTAGONISTS Public/Granted day:2018-11-15
Information query
IPC分类:
